TRIC-A Loss Sensitizes the Heart to β-Adrenergic Stress and Drives Cardiomyocyte Death and Fibrosis
Biomolecules · 2026
DOI: 10.3390/biom16020181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Ki Ho Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Sciences, University of Virginia, Charlottesville, VA 22903, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, Japan Society for the Promotion of Science, National Institutes of Health.
Abstract (Originalsprache)
Trimeric intracellular cation channel A (TRIC-A) provides counter-ion support for sarcoplasmic reticulum (SR) Ca2+ release, yet its physiological role in the intact heart under stress remains poorly defined. Here, we demonstrate that TRIC-A is essential for maintaining balanced SR Ca2+ release, mitochondrial integrity, and cardiac resilience during β-adrenergic stimulation. Tric-a−/− cardiomyocytes exhibited Ca2+ transients evoked by electrical stimuli and exaggerated isoproterenol (ISO)-evoked Ca2+ release, consistent with SR Ca2+ overload. These defects were accompanied by selective upregulation of protein kinase A (PKA)-dependent phosphorylation of ryanodine receptor 2 (RyR2) (S2808) and phospholamban (PLB) (S16). Acute ISO challenge induced mitochondrial swelling, cristae disruption, and Evans Blue Dye uptake, and elevated circulating troponin T in Tric-a−/− hearts, hallmarks of necrosis-like cell death. Mitochondrial Ca2+ uptake inhibition with Ru360 markedly reduced membrane injury, establishing mitochondrial Ca2+ overload as the proximal trigger of cardiac cell death. With sustained β-adrenergic stimulation by ISO, Tric-a−/− hearts developed extensive interstitial and perivascular fibrosis without exaggerated hypertrophy. Cardiac fibroblasts lacked TRIC-A expression and displayed normal Ca2+ signaling and activation, indicating that fibrosis arises secondarily from cardiomyocyte injury rather than fibroblast-intrinsic abnormalities. These findings identify TRIC-A as a critical regulator of SR-mitochondrial Ca2+ coupling and a key molecular safeguard that protects the heart from catecholamine-induced injury and maladaptive remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Surgical Sciences, University of Virginia, Charlottesville, VA 22903, USA.
- Research Unit for Physiological Chemistry, the Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto 606-8502, Japan.
- Department of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
- Division of Pharmacology, National Institute of Health Sciences, Kawasaki 210-9501, Japan.
- Department of Anatomy, Saitama Medical University, Saitama 350-0495, Japan.
- Department of Kinesiology, University of Texas at Arlington, Arlington, TX 76010, USA.
ORCID-Profile: Ki Ho Park, Chengzhu Zhao
Förderung
- National Institute of Health
- Japan Society for the Promotion of Science
- National Institutes of Health
- JSPS KAKENHI
Zitieren
APA
Park, K. H., Yamazaki, D., Zhou, X., Komazaki, S., Zhao, C., Nishi, M., Zhou, J., Takeshima, H., & Ma, J. (2026). TRIC-A Loss Sensitizes the Heart to β-Adrenergic Stress and Drives Cardiomyocyte Death and Fibrosis. Biomolecules. https://doi.org/10.3390/biom16020181
Vancouver
Park KH, Yamazaki D, Zhou X, Komazaki S, Zhao C, Nishi M, et al. TRIC-A Loss Sensitizes the Heart to β-Adrenergic Stress and Drives Cardiomyocyte Death and Fibrosis. Biomolecules. 2026. doi:10.3390/biom16020181
BibTeX
@article{Park2026,
author = {Park, Ki Ho and Yamazaki, Daiju and Zhou, Xinyu and Komazaki, Shinji and Zhao, Chengzhu and Nishi, Miyuki and Zhou, Jingsong and Takeshima, Hiroshi and Ma, Jianjie},
title = {TRIC-A Loss Sensitizes the Heart to β-Adrenergic Stress and Drives Cardiomyocyte Death and Fibrosis},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16020181}
}
EUVIMED